Perspectives on an Intensive Hospital-Based Smoking Cessation Intervention in Relation to Transurethral Resection of the Bladder Tumour (TURBT): Interviews with Patients, Relatives, and Clinicians
- PMID: 40283780
- PMCID: PMC12026795
- DOI: 10.3390/ijerph22040555
Perspectives on an Intensive Hospital-Based Smoking Cessation Intervention in Relation to Transurethral Resection of the Bladder Tumour (TURBT): Interviews with Patients, Relatives, and Clinicians
Abstract
Smoking is a major risk factor for bladder cancer and postoperative complications. Therefore, urological guidelines strongly recommend smoking cessation. Notwithstanding, many patients continue to smoke beyond the time of diagnosis. By using the qualitative methodology, this study aimed to explore barriers, facilitators, and recommendations related to the intensive smoking cessation Gold Standard Programme (GSP) from the multi-perspective view of patients treated with transurethral resection of the bladder tumour (TURBT), their relatives, and clinicians. We conducted semi-structured individual interviews with eight patients, four relatives, and six clinicians in the urology setting. Data were analysed using the Framework Method. All participants perceived the GSP positively. Across the three groups, five categories emerged describing barriers and facilitators: perceptions of the GSP, pragmatic factors, health-related factors, psychological factors, and relational and communicative factors. Similarly, recommendations were represented in two categories: the GSP and pragmatic factors. While facilitators were relatively similar across the three groups, barriers were dissimilar or contradictory. The clinicians expressed the most challenges related to relational and communicative factors. The patients mainly had recommendations related to the GSP, while the clinicians' recommendations focused on pragmatic factors for conducting the GSP. The potential involvement of relatives needs to be further investigated.
Keywords: GSP; TURBT; bladder cancer; multi-perspective interviews; smoking cessation intervention; transurethral resection of bladder tumours.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Similar articles
-
Perioperative Intensive Smoking Cessation Intervention Among Smokers Who Underwent Transurethral Resection of Bladder Tumor (TURBT) in Two Different Settings: A Randomized Controlled Trial.Cancers (Basel). 2025 Feb 19;17(4):713. doi: 10.3390/cancers17040713. Cancers (Basel). 2025. PMID: 40002306 Free PMC article.
-
The Potential for Lifestyle Intervention Among Patients Undergoing Transurethral Resection of Bladder Tumour Based on Patient Needs Including Smoking and Other Risky Lifestyle Factors: A Cross-Sectional Study.Int J Environ Res Public Health. 2024 Dec 8;21(12):1633. doi: 10.3390/ijerph21121633. Int J Environ Res Public Health. 2024. PMID: 39767473 Free PMC article.
-
Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences.BMC Cancer. 2017 Nov 25;17(1):793. doi: 10.1186/s12885-017-3792-5. BMC Cancer. 2017. PMID: 29178899 Free PMC article.
-
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.Eur Urol. 2020 Oct;78(4):546-569. doi: 10.1016/j.eururo.2020.04.059. Epub 2020 May 8. Eur Urol. 2020. PMID: 32389447
-
Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 Aug 12;21(12):1-123. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34484486 Free PMC article.
References
-
- Gontero P., Birtle A., Compérat E., Escrig J.L.D., Liedberg F., Mariappan P., Mostafid A.H., Van Rhijn B.W.G., Seisen T., Shariat S.F., et al. EAU Guidelines on Bladder Cancer (TaT1 and CIS) Edn; Proceedings of the EAU Annual Congress Paris 2024; Paris, France. 5–8 April 2024; Arnhem, The Netherlands: EAU Guidelines Office; 2024.
-
- Caini S., Del Riccio M., Vettori V., Francolini G., D’Ecclesiis O., Cai T., Gaeta A., Bonaccorsi G., Zanna I., Palli D., et al. Prognostic Impact of Post-Diagnosis Smoking Cessation among Bladder Cancer Patients: A Systematic Literature Review and Meta-Analysis. Cancers. 2022;14:4022. doi: 10.3390/cancers14164022. - DOI - PMC - PubMed
-
- Rink M., Furberg H., Zabor E.C., Xylinas E., Babjuk M., Pycha A., Lotan Y., Karakiewicz P.I., Novora G., Robinson B.D., et al. Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–Muscle-Invasive Bladder Cancer. Eur. Urol. 2013;63:724–732. doi: 10.1016/j.eururo.2012.08.025. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical